DxTerity Earns SOC 2 Type 2 Compliance, Reinforcing Commitment to Secure Healthcare Data. Read more


img white paper 1 thumbnail

IFN-1 status: what it means for your SLE patients

IFN-1 high patients are at a greater risk for severe disease


IFN-1 Test for Lupus


DxTerity® Type-1 Interferon Test for Risk Assessment

  • High IFN-1 levels increase the risks for lupus nephritis
  • Specific patient subgroups are at a greater risk for high IFN-1 and disease progression
  • IFN-1 status can serve as a prognostic indicator for disease activity and therapeutic response
img white paper 1 thumbnail



Want to learn more about IFN-1 and therapies that target the IFN-1 pathway?


View our additional resources:

IFN-1 Informational Brochure



Each lupus patient’s disease is unique, but specific biomarkers like Type-1 Interferon (IFN-1) are known to play a role in SLE disease activity.

List of illness Copy

RNA Monitoring
Protein Biomarkers


List of illness Copy

Therapy Selection
and Care Recommendations

By measuring a patient’s biomarkers, it may be possible to predict disease progression, response to standard therapy, and may help to identify patients that may benefit from targeted therapy.



Better health management begins
at home

Subscribe to receive the latest information on new developments and products at DxTerity.